Advertisement News Archives - Page 1575 of 5228 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

July 15, 2026

FDA grants priority review to Roche’s Gazyva/Gazyvaro for pMN

The US Food and Drug Administration (FDA) has granted priority review to Roche’s supplemental biologics licence application (sBLA) for Gazyva/Gazyvaro (obinutuzumab) to treat adults with primary membranous nephropathy (pMN).

FDA grants priority review to Roche’s Gazyva/Gazyvaro for pMN